Literature DB >> 10707878

Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma.

F Berr1, A Tannapfel, P Lamesch, S Pahernik, M Wiedmann, U Halm, A E Goetz, J Mössner, J Hauss.   

Abstract

BACKGROUND: Hilar bile duct carcinoma has an 80% probability of local recurrence after curative resection, which might be reduced if neoadjuvant photodynamic therapy is feasible. CASE AND TREATMENT: After intravenous injection of sodium porfimer we treated an adenocarcinoma of the proximal common bile duct (T2 N0 M0, Bismuth type II) in a 72-year-old man with red laser light (applied from the lumen at a dose 250 Joules/cm2), and the adjacent right and left hepatic and common bile duct at a dose of 125 Joules/cm2. After 23 days the tumor was completely resected (adenocarcinoma pT2 pNO; G2).
RESULTS: In the lumenal, 4-mm-thick layer the bile duct specimen exhibited complete tumor necrosis with pigmentation of photodegraded porfimer and no viable tumor cells, while in the outer layer of the wall (at 5-8-mm depth) viable cancer cell nests without degraded porfimer were seen. The bile duct tissue showed little damage. Eighteen months after surgery, neither tumor recurrence nor stricture formation was found at the pretreated bilioenteric anastomoses.
CONCLUSIONS: a) Photodynamic therapy with sodium porfimer seems to be confined to the superficial 4-mm layer of bile duct cancer. b) Neoadjuvant photodynamic therapy is feasible for hilar bile duct carcinoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10707878     DOI: 10.1016/s0168-8278(00)80083-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  14 in total

Review 1.  Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.

Authors:  J R A Skipworth; S W M Olde Damink; C Imber; J Bridgewater; S P Pereira; M Malagó
Journal:  Aliment Pharmacol Ther       Date:  2011-09-20       Impact factor: 8.171

2.  Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

Authors:  Helmut Witzigmann; Frieder Berr; Ulrike Ringel; Karel Caca; Dirk Uhlmann; Konrad Schoppmeyer; Andrea Tannapfel; Christian Wittekind; Joachim Mossner; Johann Hauss; Marcus Wiedmann
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

Review 3.  Photodynamic therapy for pancreatic and biliary tract carcinoma.

Authors:  Lakshmana Ayaru; Stephen G Bown; Stephen P Pereira
Journal:  Int J Gastrointest Cancer       Date:  2005

4.  Photodynamic therapy for biliary tract organ via a novel ultra-small composite optical fiberscope.

Authors:  Kazuhiko Kasuya; Kiyoshi Oka; Ryoko Soya; Takaaki Tsuchiya; Takao Itoi; Akihiko Tsuchida
Journal:  Exp Ther Med       Date:  2017-08-28       Impact factor: 2.447

5.  Current status of photodynamic therapy for bile duct cancer.

Authors:  Tae Yoon Lee; Young Koog Cheon; Chan Sup Shim
Journal:  Clin Endosc       Date:  2013-01-31

6.  Radiofrequency ablation as a treatment for hilar cholangiocarcinoma.

Authors:  Wei-Jun Fan; Pei-Hong Wu; Liang Zhang; Jin-Hua Huang; Fu-Jun Zhang; Yang-Kui Gu; Ming Zhao; Xiang-Long Huang; Chang-Yu Guo
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

Review 7.  Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review.

Authors:  Jan Grendar; Petra Grendarova; Richie Sinha; Elijah Dixon
Journal:  HPB (Oxford)       Date:  2013-08-26       Impact factor: 3.647

8.  Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma.

Authors:  Tae Yoon Lee; Young Koog Cheon; Chan Sup Shim; Young Deok Cho
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

Review 9.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.

Authors:  Demian van Straten; Vida Mashayekhi; Henriette S de Bruijn; Sabrina Oliveira; Dominic J Robinson
Journal:  Cancers (Basel)       Date:  2017-02-18       Impact factor: 6.639

Review 10.  Palliative Endoscopic Treatment Options in Malignancies of the Biliopancreatic System.

Authors:  Jürgen Feisthammel; Joachim Mössner; Albrecht Hoffmeister
Journal:  Viszeralmedizin       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.